Laryngeal Cancer Overview
Learn About Laryngeal Cancer
Jefferson University Physicians
Joseph Curry is an Otolaryngologist in Philadelphia, Pennsylvania. Dr. Curry is rated as an Elite provider by MediFind in the treatment of Laryngeal Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Duct Stones, Throat Cancer, Laryngectomy, and Gastrostomy.
Jefferson University Physicians
Adam Luginbuhl is an Otolaryngologist in Philadelphia, Pennsylvania. Dr. Luginbuhl is rated as an Elite provider by MediFind in the treatment of Laryngeal Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Throat Cancer, Laryngectomy, and Gastrostomy.
Proliance Surgeons
Craig Villari, MD, is a board-certified otolaryngologist. He treats a broad spectrum of ear, nose, and throat conditions in both adults and children. He has a special interest in caring for voice, airway, and swallowing concerns and is a post-graduate member of the American Laryngologic Society. He takes great pride in making sure his patients understand their diagnoses and treatment options.Dr. Villari grew up in Buffalo, New York but spent other parts of his childhood in Saint Louis, Missouri and Fort Worth, Texas. He graduated summa cum laude from Emory University where he also completed medical training and otolaryngology residency. He completed an extra year of subspecialty training in laryngology at the University of California, San Francisco and then practiced for four years at Emory University in Atlanta, GA. He has published multiple peer-reviewed articles and book chapters, serves as a peer-reviewer for top journals, and has been an invited national and international speaker for his field.He lives on the Eastside with his wife, their son, daughter, and basset hound, Pickles. Outside of medicine, he enjoys reading, golf, and following professional sports. He's a Kraken fan and optimistic the NBA will make a return to the Emerald City. Dr. Villari is rated as a Distinguished provider by MediFind in the treatment of Laryngeal Cancer. His top areas of expertise are Recurrent Respiratory Papillomatosis, Spasmodic Dysphonia, Vocal Cord Dysfunction, Throat Cancer, and Laryngectomy.
Summary: This phase II trial compares the effectiveness of cemiplimab with CDX-1140 to cemiplimab without CDX-1140 prior to surgery in treating patients with stage III-IV head and neck cancer. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. CDX-1140 is a monoclonal antibo...
Summary: This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamous cell head and neck cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for ...
